Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cow's Milk Allergy (CMA): Evaluation of Tolerance, Efficacy and Safety of a Thickened Extensively Hydrolyzed Formula in Infants With IgE and Non-IgE Mediated CMA

NCT06481280 is registered in ClinicalTrials.gov with United Pharmaceuticals as lead sponsor.

NCT NCT06481280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06481280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cow's Milk Allergy (CMA): Evaluation of Tolerance, Efficacy and Safety of a Thickened Extensively Hydrolyzed Formula in Infants With IgE and Non-IgE Mediated CMA
Lead sponsor
United Pharmaceuticals
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 14, 2024
Completion date
June 30, 2026
Enrollment
70 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cow's milk allergy